Insmed/$INSM
About Insmed
Ticker
Industry
Employees
Insmed Metrics
$12B
-
-$5.56
1.11
-
Price and volume
Market cap
$12B
Beta
1.11
52-week high
$80.53
52-week low
$21.92
Average daily volume
1.8M
Financial strength
Current ratio
6.365
Quick ratio
5.827
Long term debt to equity
237.769
Total debt to equity
239.942
Interest coverage (TTM)
-8.45%
Management effectiveness
Return on assets (TTM)
-26.05%
Return on equity (TTM)
-890.75%
Valuation
Price to revenue (TTM)
31.248
Price to book
25.5
Price to tangible book (TTM)
42.9
Price to free cash flow (TTM)
-16.85
Growth
Revenue change (TTM)
22.13%
Earnings per share change (TTM)
5.62%
3-year revenue growth (CAGR)
25.44%
3-year earnings per share growth (CAGR)
12.37%
What the Analysts think about Insmed
Analyst Ratings
Insmed Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Insmed Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Insmed News
FAQs
What’s the current market cap for Insmed stock?
What is the P/E ratio for Insmed stock?
Does Insmed stock pay dividends?
No, Insmed (INSM) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Insmed dividend payment date?
Insmed (INSM) stock does not pay dividends to its shareholders.
What is the beta indicator for Insmed?
Insmed (INSM) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.